arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Fate Therapeutics, Inc.

FATE Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.11
▲ +1.9% Today
as of Oct 23, 16:02 ET
Last 30 days -9.83% Sep 14 → Oct 23
$1.73 $1.96 $2.18 $2.41 $2.64 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.07
High
$2.11
Low
$2.04
Volume
$862,791
Avg Vol
$2M
Mkt Cap
$276M
P/E (TTM)
—
Beta
—
52w High
$3.23
52w Low
$0.95
Div Yield
—
Shares Out
$117M

Recent Press Releases & News last 60 days · 8 items

Oct 12 · 11:00 PR GlobeNewswire
Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies
Oct 2 · 11:00 PR GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Oct 1 · 11:00 PR GlobeNewswire
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
▸ Show all 8 press releases & news Free account →

FATE earnings at a glance

The options market is pricing a move of about ±48.0% after the report, a range of roughly $1.10 to $3.12 from today's $2.11. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±5.7% on average; after the most recent report on May 13, 2026 it moved -4.9%. That means options currently expect more movement than FATE has typically delivered. FATE beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 364%. The share price of $2.11 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.95
$3.23
51% of range
Avg surprise (last 4)
+13.1%
Avg reaction (last 2)
-5.7%
0% positive
Latest IV / EM
364%
EM ±48.0% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.54$-0.45$-0.36$-0.28$-0.19 Actual $-0.19Actual $-0.54Actual $-0.46Actual $-0.47Actual $-0.33Actual $-0.40Actual $-0.32Est $-0.39Actual $-0.29Est $-0.35Actual $-0.27Est $-0.29Actual $-0.26Est $-0.29Actual $-0.25 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-48M$-35M$-22M$-9M$3M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.25 — — — — financials
Wed May 13, 2026Mar/2026 $-0.26 $-0.29 +10.3% +18.8% -4.9% earnings
Thu Nov 13, 2025Sep/2025 $-0.27 $-0.29 +6.9% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.29 $-0.35 +17.1% — — earnings
Tue May 13, 2025Mar/2025 $-0.32 $-0.39 +17.9% — -6.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.40 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.33 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.47 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.46 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.54 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.19 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$2M$1M—$2M$2M$2M—$3M
Cost of revenue————————
Gross profit————————
Operating income$-31M$-33M—$-35M$-37M$-41M—$-52M
Net income$-30M$-31M—$-32M$-34M$-38M—$-48M
EPS (diluted)$-0.25$-0.26—$-0.27$-0.29$-0.32—$-0.40

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$32M$40M$47M$41M$41M$45M$36M$38M
Inventory————————
Total current assets$158M$180M$209M$221M$230M$248M$292M$310M
Total assets$260M$285M$319M$344M$372M$399M$441M$495M
Long-term debt————————
Total liabilities————————
Total equity$153M$180M$207M$234M$261M$288M$319M$362M

Implied volatility — last 90 days

38%346%654%962%1270% Jun 07 — IV 164% · EM ±22.7%Jun 08 — IV 119% · EM ±15.7%Jun 09 — IV 116% · EM ±14.5%Jun 10 — IV 158% · EM ±18.7%Jun 11 — IV 138% · EM ±15.2%Jun 12 — IV 142% · EM ±14.6%Jun 15 — IV 206% · EM ±14.9%Jun 16 — IV 223% · EM ±13.2%Jun 17 — IV 244% · EM ±10.2%Jun 19 — IV 108% · EM ±23.9%Jun 22 — IV 200% · EM ±41.8%Jun 23 — IV 124% · EM ±25.5%Jun 26 — IV 143% · EM ±27.4%Jun 29 — IV 292% · EM ±51.7%Jun 30 — IV 177% · EM ±30.6%Jul 01 — IV 126% · EM ±21.0%Jul 06 — IV 133% · EM ±18.4%Jul 07 — IV 188% · EM ±24.8%Jul 08 — IV 109% · EM ±13.7%Jul 09 — IV 136% · EM ±16.0%Jul 13 — IV 238% · EM ±19.9%Jul 14 — IV 289% · EM ±20.9%Jul 15 — IV 338% · EM ±19.9%Jul 16 — IV 482% · EM ±20.1%Jul 20 — IV 155% · EM ±36.6%Jul 21 — IV 137% · EM ±31.8%Jul 22 — IV 123% · EM ±28.1%Jul 23 — IV 472% · EM ±106.2%Jul 24 — IV 225% · EM ±49.8%Jul 28 — IV 316% · EM ±64.7%Jul 29 — IV 222% · EM ±44.5%Jul 30 — IV 346% · EM ±67.7%Jul 31 — IV 277% · EM ±53.1%Aug 03 — IV 248% · EM ±44.0%Aug 04 — IV 232% · EM ±39.9%Aug 05 — IV 115% · EM ±19.2%Aug 07 — IV 217% · EM ±33.9%Aug 10 — IV 170% · EM ±23.6%Aug 11 — IV 249% · EM ±32.8%Aug 12 — IV 308% · EM ±38.6%Aug 13 — IV 259% · EM ±30.7%Aug 14 — IV 352% · EM ±38.9%Aug 18 — IV 432% · EM ±31.2%Aug 20 — IV 1271% · EM ±53.1%Aug 25 — IV 211% · EM ±43.1%Aug 26 — IV 39% · EM ±7.8%Aug 28 — IV 290% · EM ±55.6%Aug 31 — IV 295% · EM ±52.3%Sep 01 — IV 311% · EM ±53.5%Sep 02 — IV 318% · EM ±53.1%Sep 03 — IV 332% · EM ±53.7%Sep 04 — IV 387% · EM ±60.5%Sep 07 — IV 437% · EM ±60.5%Sep 09 — IV 393% · EM ±49.2%Sep 10 — IV 400% · EM ±47.2%Sep 17 — IV 1235% · EM ±51.6%Sep 21 — IV 170% · EM ±35.6%Sep 22 — IV 189% · EM ±38.8%Sep 23 — IV 308% · EM ±61.7%Sep 24 — IV 198% · EM ±38.8%Sep 25 — IV 231% · EM ±44.3%Sep 28 — IV 273% · EM ±48.3%Sep 29 — IV 268% · EM ±46.2%Sep 30 — IV 303% · EM ±50.6%Oct 06 — IV 364% · EM ±48.0%

Sector peers

SABS
SAB Biotherapeutics, Inc.
$278M $2.84+0.7%
XFOR
X4 Pharmaceuticals, Inc.
$279M $3.24+7.6%
LXEO
Lexeo Therapeutics, Inc.
$272M $2.80-6.7%
IKT
Inhibikase Therapeutics, Inc.
$269M $1.59-4.2%
IPSC
Century Therapeutics, Inc.
$292M $1.46-9.3%
SRZN
Surrozen, Inc.
$296M $25.48+0.6%

FATE earnings FAQ

What is FATE's expected move for earnings?

Options currently price a move of about ±48.0%, or $1.01 per share either way from $2.11.

How does FATE stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.7%, up 0 times and down 2 times.

What is FATE's implied volatility?

FATE's at-the-money implied volatility is about 364% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in